|
1.
|
|
|
Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment
/
Cantó, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ;
Anguera, Georgia (Hospital de la Santa Creu i Sant Pau) ;
Jiménez, Natalia (Institut d’Investigacions Biomèdiques August Pi i Sunyer) ;
Mellado, Begoña (Institut d’Investigacions Biomèdiques August Pi i Sunyer) ;
Ramírez, Ona (Institut d'Investigació Biomèdica Sant Pau) ;
Mariscal, Anaís (Institut d'Investigació Biomèdica Sant Pau) ;
Maroto Rey, Pablo (Hospital de la Santa Creu i Sant Pau) ;
Vidal, Silvia (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
(1) Background: Prostate cancer is the second most common cancer in men, with androgen suppression as the standard treatment. Despite initially responding to castration, most metastatic prostate cancer patients eventually experience progression. [...]
2023 -  10.3390/diagnostics13132222
Diagnostics, Vol. 13, Num. 13 (june 2023)
|
|
|
2.
|
|
|
Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat : a modified Delphi study
/
Bichet, Daniel G. (University of Montréal, Canada) ;
Hopkin, Robert J. (University of Cincinnati College of Medicine, United States) ;
Aguiar, Patrício (Lisbon University) ;
Allam, Sridhar R. (Texas Christian University, Fort Worth, United States) ;
Chien, Yin-Hsiu (National Taiwan University College of Medicine, Taipei, Taiwan) ;
Giugliani, Roberto (Postgraduate Program in Genetics and Molecular Biology (PPGBM) at Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil) ;
Kallish, Staci (University of Pennsylvania, Philadelphia, United States) ;
Kineen, Sabina (Patient Advocate, United States) ;
Lidove, Olivier (French Network of Inherited Metabolic Disorders (G2m), France) ;
Niu, Dau-Ming (National Yang Ming Chiao Tung University, Taipei, Taiwan) ;
Olivotto, Iacopo (Meyer University Children's Hospital, Florence, Italy) ;
Politei, Juan (Fundacion Para el Estudio de Enfermedades Neurometabolicas (FESEN), Buenos Aires, Argentina) ;
Rakoski, Paul (Patient Advocate, United States) ;
Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ;
Tøndel, Camilla (University of Bergen, Norway) ;
Hughes, Derralynn A. (Royal Free London NHS Foundation Trust and University College London, United Kingdom) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Fabry disease is a progressive disorder caused by deficiency of the α-galactosidase A enzyme (α-Gal A), leading to multisystemic organ damage with heterogenous clinical presentation. The addition of the oral chaperone therapy migalastat to the available treatment options for Fabry disease is not yet universally reflected in all treatment guidelines. [...]
2023 - 10.3389/fmed.2023.1220637
Frontiers in Medicine, Vol. 10 (september 2023)
|
|
|
3.
|
|
|
Influence of body mass index on recurrence of atrial fibrillation after electrical cardioversion
/
Ligero, Carmen (Hospital Universitari de Sant Joan, Universitat Rovira i Virgili) ;
Bazán, Víctor (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Guerra, José Maria (Hospital de la Santa Creu i Sant Pau) ;
Rodríguez-Mañero, Moisés (Hospital Clínico Universitario de Santiago, Santiago de Compostela) ;
Viñolas, Xavier (Hospital de la Santa Creu i Sant Pau) ;
Alegret i Colomé, Josep Maria (Hospital Universitari de Sant Joan, Universitat Rovira i Virgili) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Several studies have shown an independent relationship between body mass index (BMI) and the incidence of atrial fibrillation (AF). However, little is known about the influence of BMI on AF recurrence after electrical cardioversion (ECV). [...]
2023 - 10.1371/journal.pone.0291938
PloS one, Vol. 18 (september 2023)
|
|
|
4.
|
|
|
Prodromal symptoms and the duration of untreated psychosis in first episode of psychosis patients : what differences are there between early vs. adult onset and between schizophrenia vs. bipolar disorder?
/
Baeza, Inmaculada (Hospital Clínic i Provincial de Barcelona) ;
de la Serna, Elena (Hospital Clínic i Provincial de Barcelona) ;
Mezquida, Gisela (Hospital Clínic i Provincial de Barcelona) ;
Cuesta, Manuel J. (Complejo Hospitalario de Navarra) ;
Vieta, Eduard (Hospital Clínic i Provincial de Barcelona) ;
Amoretti, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lobo, Antonio (Universidad de Zaragoza) ;
González-Pinto, Ana (Hospital Universitario de Alava) ;
Díaz-Caneja, Covadonga M. (Hospital General Universitario Gregorio Marañón) ;
Corripio, Iluminada (Institut d'Investigació Biomèdica Sant Pau) ;
Valli, Isabel (King's College London) ;
Puig, Olga (Hospital Clínic i Provincial de Barcelona) ;
Mané, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Bioque, Miquel (Hospital Clínic i Provincial de Barcelona) ;
Ayora, Miriam (Hospital General Universitario Gregorio Marañón) ;
Bernardo, Miquel (Hospital Clínic i Provincial de Barcelona) ;
Castro-Fornieles, Josefina (Hospital Clínic i Provincial de Barcelona) ;
García-Rizo, Clemente (Hospital Clínic i Provincial de Barcelona) ;
González-Díaz, Jairo (Hospital Clínic i Provincial de Barcelona) ;
Grasa, Eva (Institut d'Investigació Biomèdica Sant Pau) ;
Roldán, Alejandra (Institut d'Investigació Biomèdica Sant Pau) ;
Casanovas, Francesc (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Toll, Alba (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Verdolini, Norma (Hospital Clínic i Provincial de Barcelona) ;
Sagué-Vilabella, Maria (Hospital Clínic i Provincial de Barcelona) ;
Sugranyes, Gisela (Hospital Clínic i Provincial de Barcelona) ;
Ilzarbe, Daniel (Hospital Clínic i Provincial de Barcelona) ;
Contreras, Fernando (Institut d'Investigació Biomèdica de Bellvitge) ;
Universitat Autònoma de Barcelona
To assess the role of age (early onset psychosis-EOP < 18 years vs. adult onset psychosis-AOP) and diagnosis (schizophrenia spectrum disorders-SSD vs. bipolar disorders-BD) on the duration of untreated psychosis (DUP) and prodromal symptoms in a sample of patients with a first episode of psychosis. [...]
2023 - 10.1007/s00787-023-02196-7
European child and adolescent psychiatry, Vol. 33 (april 2023) , p. 799-810
|
|
|
5.
|
|
|
Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome : a 3-year follow-up cohort study
/
Park, Hye-Sang (Institut de Recerca Sant Pau) ;
Martinez-Martinez, Laura (Institut de Recerca Sant Pau) ;
Magallares López, Berta Paula (Institut de Recerca Sant Pau) ;
Castellvi, Ivan (Institut de Recerca Sant Pau) ;
Moya, Patricia (Institut de Recerca Sant Pau) ;
Codes-Mendez, Helena (Institut de Recerca Sant Pau) ;
Hernandez Sosa, Nerea (Institut de Recerca Sant Pau) ;
Díaz Torne, César (Institut de Recerca Sant Pau) ;
Laiz, Ana (Institut de Recerca Sant Pau) ;
Sainz, Luis (Institut de Recerca Sant Pau) ;
Tandaipan, Jose Luis (Institut de Recerca Sant Pau) ;
Mariscal, Anaís (Institut de Recerca Sant Pau) ;
Franco-Leyva, Teresa (Institut de Recerca Sant Pau) ;
Casademont i Pou, Jordi (Institut de Recerca Sant Pau) ;
Juarez, Candido (Institut de Recerca Sant Pau) ;
Corominas, Hèctor (Institut de Recerca Sant Pau) ;
Universitat Autònoma de Barcelona
This was an ambispective cohort study evaluating the prognostic significance of lymphocytic foci and its lymphoid composition in minor salivary gland biopsy (MSGB) for short-term disease flare and severity in Sjögren's syndrome (SS). [...]
2024 - 10.3389/fimmu.2024.1332924
Frontiers in immunology, Vol. 15 (february 2024)
|
|
|
6.
|
|
|
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy
/
Arqueros, Cristina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Gallardo, Alberto (Institut de Recerca Sant Pau) ;
Vidal, Silvia (Institut de Recerca Sant Pau) ;
Osuna Gómez, Rubén (Institut de Recerca Sant Pau) ;
Tibau Martorell, Ariadna (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Bell, Olga (Institut de Recerca Sant Pau) ;
Ramon y Cajal, Teresa (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Lerma Puertas, Enrique (Institut de Recerca Sant Pau) ;
Lobato-Delgado, Bárbara (Institut de Recerca Sant Pau) ;
Salazar, Juliana (Institut de Recerca Sant Pau) ;
Barnadas i Molins, Agustí (Institut de Recerca Sant Pau) ;
Universitat Autònoma de Barcelona
Currently, therapy response cannot be accurately predicted in HER2-negative breast cancer (BC). Measuring stromal tumour-infiltrating lymphocytes (sTILs) and mediators of the tumour microenvironment and characterizing tumour-infiltrating immune cells (TIICs) may improve treatment response in the neoadjuvant setting. [...]
2024 - 10.3390/ijms25052627
International journal of molecular sciences, Vol. 25 (february 2024)
|
|
|
7.
|
|
|
8.
|
|
|
Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy
/
Ribeiro-Constante, Juliana (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Tristán-Noguero, A. (Institut de Recerca Sant Pau) ;
Martínez Calvo, Fernando Francisco (Hospital Universitario Miguel Servet) ;
Ibañez-Mico, Salvador (Hospital Universitario de Arrixaca) ;
Peña Segura, José Luis (Hospital Universitario Miguel Servet) ;
Ramos-Fernández, José Miguel (Hospital Regional Universitario de Málaga) ;
Moyano Chicano, María del Carmen (Hospital Regional Universitario de Málaga) ;
Camino León, Rafael (Hospital Universitario Reina Sofía) ;
Soto Insuga, Víctor (Hospital Universitario Infantil del Niño Jesús) ;
González Alguacil, Elena (Hospital Universitario Infantil del Niño Jesús) ;
Valera Dávila, Carlos (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Fernández-Jaén, Alberto (Hospital Universitario Quironsalud) ;
Plans, Laura (Xarxa Assistencial) ;
Camacho, Ana (Universidad Complutense de Madrid) ;
Visa-Reñé, Nuria (Hospital Universitario Arnau de Vilanova) ;
Martin-Tamayo Blázquez, María del Pilar (Hospital General Universitario de Jerez de la Frontera) ;
Paredes-Carmona, Fernando (Hospital Universitario Arnau de Vilanova) ;
Marti-Carrera, Itxaso (Hospital Universitario Donostia) ;
Hernández-Fabián, Aránzazu (Complejo Asistencial Universitario de Salamanca) ;
Tomas Davi, Meritxell (Xarxa Assistencial) ;
Sanchez, Merce Casadesus (Xarxa Assistencial) ;
Herraiz, Laura Cuesta (Hospital de Manises) ;
Pita, Patricia Fuentes (Hospital Clínico Universitario Santiago de Compostela) ;
Gonzalez, Teresa Bermejo (Servicio de Neurología Pediátrica) ;
O'Callaghan, Maria del Mar (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Iglesias Santa Polonia, Federico Felipe (Hospital Universitario de Burgos) ;
Cazorla, María Rosario (Hospital Universitario Puerta de Hierro Majadahonda) ;
Ferrando Lucas, María Teresa (Hospital Universitario Quironsalud) ;
González-Meneses, Antonio (Hospital Universitario Virgen del Rocío) ;
Sala-Coromina, Júlia (Hospital Universitari Vall d'Hebron) ;
Macaya Ruiz, Alfons (Hospital Universitari Vall d'Hebron) ;
Lasa-Aranzasti, Amaia (Hospital Universitari Vall d'Hebron) ;
Cueto-González, Anna Mª (Hospital Universitari Vall d'Hebron) ;
Valera Párraga, Francisca (Hospital Universitario de Arrixaca) ;
Campistol Plana, Jaume (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Serrano, Mercedes (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Alonso, Xenia (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Del Castillo-Berges, Diego (Institut de Recerca Sant Pau) ;
Schwartz-Palleja, Marc (Universitat Pompeu Fabra) ;
Illescas, Sofía (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Ramírez Camacho, Alia (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Sans Capdevila, Oscar (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
García-Cazorla, Angels (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Bayés, Àlex (Institut de Recerca Sant Pau) ;
Alonso-Colmenero, Itziar (Hospital Sant Joan de Déu (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
SYNGAP1 haploinsufficiency results in a developmental and epileptic encephalopathy (DEE) causing generalized epilepsies accompanied by a spectrum of neurodevelopmental symptoms. Concerning interictal epileptiform discharges (IEDs) in electroencephalograms (EEG), potential biomarkers have been postulated, including changes in background activity, fixation-off sensitivity (FOS) or eye closure sensitivity (ECS). [...]
2024 - 10.3389/fcell.2024.1321282
Frontiers in Cell and Developmental Biology, Vol. 12 (march 2024)
|
|
|
9.
|
|
|
PCSK9 plasma concentration is associated with epicardial adipose tissue volume and metabolic control in patients with type 1 diabetes
/
Sardà, Helena (Hospital de la Santa Creu I Sant Pau (Barcelona, Catalunya)) ;
Colom, Cristina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Benitez, Sonia (Institut de Recerca Sant Pau) ;
Carreras, Gemma (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Amigó, Judit (Hospital Universitari Vall d'Hebrón) ;
Miñambres, Inka (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Viladés Medel, David (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Blanco Vaca, Francisco (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Sanchez-Quesada, Jose Luis (Institut de Recerca Sant Pau) ;
Pérez Pérez, Antonio (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Patients with type 1 diabetes (T1D) have a greater risk of cardiovascular disease. Proconvertase subtilisin-kexin 9 (PCSK9) is involved in the atherosclerosis process. This study aimed to determine the relationship between PCSK9 levels and epicardial adipose tissue (EAT) volume and cardiometabolic variables in patients with T1D. [...]
2024 - 10.1038/s41598-024-57708-5
Scientific reports, Vol. 14 (march 2024)
|
|
|
10.
|
|
|
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
/
Martinez-Molina, Cristina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Díaz Torne, César (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Park, Hye S (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Feliu, Anna (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Vidal, Silvia (Institut de Recerca Sant Pau) ;
Corominas, Hèctor (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Recently, a randomized controlled trial suggested a potential benefit of baricitinib in patients with diabetes mellitus, preserving β-cell function. However, the clinical evidence currently available is limited. [...]
2024 - 10.3390/medicina60030360
Medicina, Vol. 60 (february 2024)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
